Orthobiologics Global Market Report 2025

Description

Orthobiologics refer to therapies derived from natural substances utilized in treating various musculoskeletal conditions. These therapies aim to enhance the body's capacity to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments, ultimately improving recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction.

The main products of orthobiologics include viscosupplements, bone growth factors, demineralized bone matrix, synthetic bone substitutes, cellular allografts, and others. Viscosupplements are gel-like substances injected into joints to provide lubrication and cushioning, thereby reducing pain and enhancing mobility in individuals with osteoarthritis. These products find applications across various fields, including spinal fusion, maxillofacial and dental surgeries, soft tissue repair, reconstructive and fracture surgery, and others. They are utilized by various end users such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

The orthobiologics market research report is one of a series of new reports from The Business Research Company that provides orthobiologics market statistics, including the orthobiologics industry global market size, regional shares, competitors with orthobiologics market share, detailed orthobiologics market segments, market trends, and opportunities, and any further data you may need to thrive in the orthobiologics industry. These orthobiologics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthobiologics market size has grown strongly in recent years. It will grow from $7.08 billion in 2024 to $7.56 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the rise in prevalence of orthopedic diseases and conditions, shift towards minimally invasive procedures, rise in number of reconstructive surgeries, increase in healthcare expenditure, awareness among patients and healthcare providers, and economic development in emerging markets.

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

The rising incidence of road accidents and sports injuries is expected to drive the growth of the orthobiologics market in the future. Road accidents and sports injuries involve physical harm to individuals, often affecting the musculoskeletal system. These incidents are influenced by factors such as distracted driving, speeding, poor road conditions, overuse, improper equipment, and insufficient training for sports-related injuries. Orthobiologics play a key role in treating these injuries by promoting faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body's natural repair processes using substances like bone grafts, growth factors, stem cells, and platelet-rich plasma. For example, in March 2024, Eurostat, the European Union's statistical office, reported that in 2022, 20,653 people were killed in road accidents in Europe, an increase of 3.7% compared to 19,917 fatalities in 2021. As a result, the growing number of road accidents and sports injuries is expected to propel the orthobiologics market.

Key players in the orthobiologics market are actively developing advanced solutions to improve bone healing and fusion in orthopedic procedures. Dry allograft mixtures, for instance, combine sturdy cortical fibers with mineralized cortical bone, offering structural support and promoting osteoinductive properties for new bone formation. Isto Biologics, a US-based biologics-focused company, introduced Fibrant Liberty allograft in May 2024, featuring robust cortical fibers integrated with mineralized cortical cancellous chips. This graft, upon hydration, becomes pliable and can be tailored for various surgical procedures. Its longer and stronger fibers improve handling and form a network that prevents graft migration while maintaining structural integrity.

In February 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, completed the acquisition of Embody Inc. for $155 million. This strategic move underscores Zimmer's commitment to investing in areas with significant growth potential and introducing innovations to benefit patients and surgeons. Embody, a US-based soft tissue healing company, specializes in developing and manufacturing collagen-based biologic products for soft tissue augmentation and repair. The acquisition includes Embody's comprehensive portfolio of collagen-based biointegrative solutions aimed at supporting healing in challenging orthopedic soft tissue injuries.

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

North America was the largest region in the orthobiologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orthobiologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orthobiologics market consists of sales of bone morphogenetic proteins, hyaluronic acid, stem cells, and platelet-rich plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthobiologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthobiologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthobiologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orthobiologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products
2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications
3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users
Subsegments:
1) By Viscosupplements: Hyaluronic Acid Injections; Gel-Based Viscosupplements; Cross-linked Hyaluronic Acid; Other Viscosupplement Products
2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs); Recombinant Human Bone Morphogenetic Proteins (rhBMPs); Platelet-Rich Plasma (PRP); Osteogenic Protein-1 (OP-1); Growth Factors For Bone Healing
3) By Demineralized Bone Matrix: DBM Grafts; DBM Putty; DBM Sponges; DBM Paste And Chips
4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes; Calcium Sulfate-Based Substitutes; Tricalcium Phosphate (TCP); Hydroxyapatite (HA); Bioactive Glasses; Other Synthetic Bone Substitutes
5) By Cellular Allograft: Osteocellular Allografts; Mesenchymal Stem Cells (MSCs) Allografts; Bone Marrow-Derived Cellular Allografts; Adipose Tissue-Derived Cellular Allografts
6) By Other Products: Autografts; Collagen-Based Grafts; Synthetic Bone Graft Substitutes (Non-Bioactive); Amniotic Membrane-Based Grafts; Exosome-Based Products; Other Miscellaneous Orthobiologic Products
Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet; Arthrex Inc.; Integra Lifesciences Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30858

1. Executive Summary

2. Orthobiologics Market Characteristics

3. Orthobiologics Market Trends And Strategies

4. Orthobiologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Orthobiologics Growth Analysis And Strategic Analysis Framework

5.1. Global Orthobiologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Orthobiologics Market Growth Rate Analysis
5.4. Global Orthobiologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Orthobiologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Orthobiologics Total Addressable Market (TAM)

6. Orthobiologics Market Segmentation

6.1. Global Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viscosupplements
Bone Growth Factors
Demeneralized Bone Matrix
Synthetic Bone Substitutes
Cellular Allograft
Other Products
6.2. Global Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spinal Fusion
Maxillofacial And Dental
Soft Tissue Repair
Reconstructive And Fracture Surgery
Other Applications
6.3. Global Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Orthopedic Clinics
Ambulatory Surgery Centers
Other End Users
6.4. Global Orthobiologics Market, Sub-Segmentation Of Viscosupplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyaluronic Acid Injections
Gel-Based Viscosupplements
Cross-linked Hyaluronic Acid
Other Viscosupplement Products
6.5. Global Orthobiologics Market, Sub-Segmentation Of Bone Growth Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Morphogenetic Proteins (BMPs)
Recombinant Human Bone Morphogenetic Proteins (rhBMPs)
Platelet-Rich Plasma (PRP)
Osteogenic Protein-1 (OP-1)
Growth Factors For Bone Healing
6.6. Global Orthobiologics Market, Sub-Segmentation Of Demineralized Bone Matrix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DBM Grafts
DBM Putty
DBM Sponges
DBM Paste And Chips
6.7. Global Orthobiologics Market, Sub-Segmentation Of Synthetic Bone Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcium Phosphate-Based Substitutes
Calcium Sulfate-Based Substitutes
Tricalcium Phosphate (TCP)
Hydroxyapatite (HA)
Bioactive Glasses
Other Synthetic Bone Substitutes
6.8. Global Orthobiologics Market, Sub-Segmentation Of Cellular Allograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Osteocellular Allografts
Mesenchymal Stem Cells (MSCs) Allografts
Bone Marrow-Derived Cellular Allografts
Adipose Tissue-Derived Cellular Allografts
6.9. Global Orthobiologics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autografts
Collagen-Based Grafts
Synthetic Bone Graft Substitutes (Non-Bioactive)
Amniotic Membrane-Based Grafts
Exosome-Based Products
Other Miscellaneous Orthobiologic Products

7. Orthobiologics Market Regional And Country Analysis

7.1. Global Orthobiologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Orthobiologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orthobiologics Market

8.1. Asia-Pacific Orthobiologics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orthobiologics Market

9.1. China Orthobiologics Market Overview
9.2. China Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orthobiologics Market

10.1. India Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orthobiologics Market

11.1. Japan Orthobiologics Market Overview
11.2. Japan Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orthobiologics Market

12.1. Australia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orthobiologics Market

13.1. Indonesia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orthobiologics Market

14.1. South Korea Orthobiologics Market Overview
14.2. South Korea Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orthobiologics Market

15.1. Western Europe Orthobiologics Market Overview
15.2. Western Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orthobiologics Market

16.1. UK Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orthobiologics Market

17.1. Germany Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orthobiologics Market

18.1. France Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orthobiologics Market

19.1. Italy Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orthobiologics Market

20.1. Spain Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orthobiologics Market

21.1. Eastern Europe Orthobiologics Market Overview
21.2. Eastern Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orthobiologics Market

22.1. Russia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orthobiologics Market

23.1. North America Orthobiologics Market Overview
23.2. North America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orthobiologics Market

24.1. USA Orthobiologics Market Overview
24.2. USA Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orthobiologics Market

25.1. Canada Orthobiologics Market Overview
25.2. Canada Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orthobiologics Market

26.1. South America Orthobiologics Market Overview
26.2. South America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orthobiologics Market

27.1. Brazil Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orthobiologics Market

28.1. Middle East Orthobiologics Market Overview
28.2. Middle East Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orthobiologics Market

29.1. Africa Orthobiologics Market Overview
29.2. Africa Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orthobiologics Market Competitive Landscape And Company Profiles

30.1. Orthobiologics Market Competitive Landscape
30.2. Orthobiologics Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Orthobiologics Market Other Major And Innovative Companies

31.1. NuVasive Inc.
31.2. Globus Medical
31.3. Bioventus
31.4. MTF Biologics
31.5. ATEC Spine Inc.
31.6. Exactech Inc.
31.7. SeaSpine
31.8. RTI Surgical
31.9. AlloSource
31.10. XTANT MEDICAL
31.11. Spine Wave Inc.
31.12. Bone Biologics Corp.
31.13. Locate Bio Limited
31.14. Wright Medical Group N.V.
31.15. BoneSupport AB

32. Global Orthobiologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Orthobiologics Market

34. Recent Developments In The Orthobiologics Market

35. Orthobiologics Market High Potential Countries, Segments and Strategies

35.1 Orthobiologics Market In 2029 - Countries Offering Most New Opportunities
35.2 Orthobiologics Market In 2029 - Segments Offering Most New Opportunities
35.3 Orthobiologics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer